A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study protocol for a randomized controlled, non-inferiority trial
Abstract Background The gonadotropin-releasing hormone (GnRH) antagonist protocol is advantageous given that it can avoid severe ovarian hyperstimulation syndrome (OHSS), especially for patients with polycystic ovary syndrome (PCOS). Basic and clinical evidence has shown that a threshold of luteiniz...
Main Authors: | Shan Liu, Ya-su Lv, Shuo Han, Minghui Liu, Shuai Ma, Haiying Ren, Yuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-022-06586-1 |
Similar Items
-
Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
by: Dan Zhang, et al.
Published: (2018-12-01) -
GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile
by: Nirja Chaudhari, et al.
Published: (2018-04-01) -
Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01) -
Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01) -
GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01)